Siegfried Hapfelmeier - Infectious Diseases

Author Information

Siegfried Hapfelmeier is a researcher affiliated with the Institute for Infectious Diseases at the University of Bern in Bern, Switzerland. His work is primarily focused on infectious diseases, exploring various aspects of bacterial interactions, host-microbiota interactions, and mucosal immunology.

Research Contributions

Siegfried Hapfelmeier has made significant contributions to the field of infectious diseases, as evidenced by his diverse array of research papers. His work includes studies on bacterial motility, biofilm formation, virulence, and host-microbiota interactions. Notable research includes the regulation of bacterial motility and biofilm formation, the role of microbiota in shaping immune responses, and innovative methodologies for investigating host-microbiota interactions, such as the production of germ-free mosquitoes. His research has helped elucidate the complex dynamics between microbes and hosts, contributing to a better understanding of infectious diseases.

Aliases

Siegfried Hapfelmeier is also known by the aliases S Hapfelmeier and S. Hapfelmeier.

Publication and Citation Metrics

Metric	Count
Total Papers	67
Total Citations	8419
H-index	31

Publications:

The stationary phase-specific sRNA fimR2 is a multifunctional regulator of bacterial motility, biofilm formation and virulence

DOI: 10.1101/2022.02.17.480891

Year: 2022

Author Correction: Uncoupling of invasive bacterial mucosal immunogenicity from pathogenicity

DOI: 10.1038/s41467-021-21096-5

Year: 2021

Plant chemistry and food web health.

DOI: 10.1111/nph.17385

Year: 2021

Production of germ-free mosquitoes via transient colonisation allows stage-specific investigation of host–microbiota interactions

DOI: 10.1038/s41467-021-21195-3

Year: 2021

Robust microbe immune recognition in the intestinal mucosa

DOI: 10.1038/s41435-021-00131-x

Year: 2021

A protocol for generating germ-free Heligmosomoides polygyrus bakeri larvae for gnotobiotic helminth infection studies

DOI: 10.1016/j.xpro.2021.100946

Year: 2021

Author response: Respiratory tissue-associated commensal bacteria offer therapeutic potential against pneumococcal colonization

DOI: 10.7554/elife.53581.sa2

Year: 2020

Mucosal or systemic microbiota exposures shape the B cell repertoire

DOI: 10.1038/s41586-020-2564-6

Year: 2020

Biogeography of microbial bile acid transformations along the murine gut

DOI: 10.1194/jlr.RA120001021

Year: 2020

Uncoupling of invasive bacterial mucosal immunogenicity from pathogenicity

DOI: 10.1038/s41467-020-15891-9

Year: 2020

How Does Viral Interference Occur?

What Are the Latest Advances in Immunotherapy?

Why Is Understanding Transmission Routes Important?

What is the future of RT-PCR in Infectious Diseases?

How do socio-economic factors influence the spread of infectious diseases?

What is the Prognosis for Ebola Patients?

Can Climate Change Influence Antibiotic Resistance?

What is Conjunctivitis?

What is Ebola Virus?

What is Infectious Disease Surveillance?

Partnered Content Networks

Relevant Topics